10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,324,000 | – | 116,715 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |